These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 10082175)
1. Isoniazid and rifampicin rarely cause acute pancreatitis in patients with tuberculosis. Chan TY Int J Clin Pharmacol Ther; 1999 Feb; 37(2):109. PubMed ID: 10082175 [No Abstract] [Full Text] [Related]
7. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo]. Pitche P; Mouzou T; Padonou C; Tchangai-Walla K Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490 [TBL] [Abstract][Full Text] [Related]
8. Osteomalacia during rifampicin and isoniazid therapy is rare in Hong Kong. Chan TY Int J Clin Pharmacol Ther; 1996 Dec; 34(12):533-4. PubMed ID: 8996847 [TBL] [Abstract][Full Text] [Related]
9. Recurrent acute pancreatitis induced by isoniazid. Chan KL; Chan HS; Lui SF; Lai KN Tuber Lung Dis; 1994 Oct; 75(5):383-5. PubMed ID: 7531009 [TBL] [Abstract][Full Text] [Related]
10. Acute pancreatitis induced by isoniazid. Izzedine H; Launay-Vacher V; Storme T; Deray G Am J Gastroenterol; 2001 Nov; 96(11):3208-9. PubMed ID: 11721781 [No Abstract] [Full Text] [Related]
12. [Apoptosis-inducing action of antituberculosis drugs of the main group in vitro]. Vasilyeva OA; Serebryakova VA; Urazova OI; Novitsky VV; Kononova TE; Naslednikova IO Antibiot Khimioter; 2010; 55(11-12):25-9. PubMed ID: 21574422 [TBL] [Abstract][Full Text] [Related]
13. [Reasons for drug-resistant tuberculosis emergence]. Tu DH Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006 [No Abstract] [Full Text] [Related]
14. [Acute liver insufficiency caused by rifampicin-isoniazid]. Schalm SW; Taal BG Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1020-1. PubMed ID: 7402379 [No Abstract] [Full Text] [Related]
15. [Launois-Bensaude disease; etiopathogenic discussion in a patient treated with tuberculostatic agents]. Warembourg H; Jaillard J; Carre A; Perrard C; Ginestet A; Beuscart F Lille Med; 1975 Feb; 20(2):102-6. PubMed ID: 1142984 [No Abstract] [Full Text] [Related]
17. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach. Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R; Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298 [TBL] [Abstract][Full Text] [Related]
18. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report. Teo SK Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877 [TBL] [Abstract][Full Text] [Related]